Wordt geladen...
Antibody Drug Conjugates: Preclinical Considerations
The development path for antibody drug conjugates (ADCs) is more complex and challenging than for unmodified antibodies. While many of the preclinical considerations for both unmodified and antibody drug conjugates are shared, special considerations must be taken into account when developing an ADC....
Bewaard in:
| Gepubliceerd in: | AAPS J |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406963/ https://ncbi.nlm.nih.gov/pubmed/25724883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-015-9738-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|